Cleared Traditional

K894609 - MARDX LYME DISEASE IFA (IGM) TEST SYSTEM

K894609 is an FDA 510(k) clearance for MARDX LYME DISEASE IFA (IGM) TEST SYSTEM, manufactured by Mardx, Inc.. The device is a Class 2 Microbiology device with product code LSR cleared through the Traditional 510(k) pathway after a 61-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1989
Decision
61d
Days
Class 2
Risk

K894609 is an FDA 510(k) clearance for the MARDX LYME DISEASE IFA (IGM) TEST SYSTEM. Classified as Reagent, Borrelia Serological Reagent (product code LSR), Class II - Special Controls.

Submitted by Mardx, Inc. (Scotch Plains, US). The FDA issued a Cleared decision on September 19, 1989 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K894609

510(k) Number K894609 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 20, 1989
Decision Date September 19, 1989
Days to Decision 61 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 102d · This submission: 61d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LSR Device Classification - Class 2, Special Controls

Product Code LSR Reagent, Borrelia Serological Reagent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LSR Reagent, Borrelia Serological Reagent

All 111
Devices cleared under the same product code (LSR) and FDA review panel - the closest regulatory comparables to K894609.
BION BORRELIA BURGDORFERI ANTIGEN SUBSTRATE SLIDE
K901054 · Bion Ent., Ltd. · Apr 1990
LYME IGG ELISA TEST SYSTEM
K895292 · Zeus Scientific, Inc. · Dec 1989
IMMUNODOT LYME TEST
K894410 · General Biometrics, Inc. · Oct 1989
MARDX LYME DISEASE EIA (IGG) TEST SYSTEM
K894224 · Mardx Diagnostics, Inc. · Aug 1989
MARDX LYME DISEASE EIA (IGM) TEST SYSTEM
K894293 · Mardx Diagnostics, Inc. · Aug 1989
MARDX LLYME DISEASE EIA (IGG & IGM) TEST SYSTEM
K892206 · Mardx Diagnostics, Inc. · Aug 1989